Related Experiment Video
Updated: Aug 1, 2026

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation
Published on: April 2, 2012
Persistence of infectious herpes simplex virus type 2 in the nervous system in mice after antiviral chemotherapy
1Centre for Veterinary Science, Cambridge University Veterinary School, Cambridge CB3 0ES, United Kingdom.
Abstract:
Young adult mice were inoculated with herpes simplex virus type 2 (HSV-2) in the ear pinna. A relatively severe infection resulted, and 45% of the mice died by 11 days postinfection. Therapy at 1 mg/ml by means of the drinking water with either famciclovir for periods of 5 or 10 days or valaciclovir for 5, 10, 15, or 20 days decreased clinical signs and reduced mortality to 15% or less. Throughout a period of 27 days, mice were tested daily for the presence of infectious virus in the ear pinna, brain stem, and ipsilateral trigeminal ganglia. Virus was cleared from these tissues in surviving, untreated animals by 12 days postinfection, and no infectious virus was detected subsequently in any tissue. Furthermore, no infectious virus was detected after day 9 in mice that had been treated with famciclovir. In mice that had received valaciclovir therapy, however, infectious virus was repeatedly detected in the trigeminal ganglia and brain stem tissue samples up to 7 days after treatment was discontinued. To date, no specific mechanism to account for these results has been discovered; however, possible mechanisms for the persistence of potentially infectious virus in neural tissue of treated mice are discussed.
Insights
Famciclovir and valaciclovir treatments reduced mortality in herpes simplex virus type 2 (HSV-2) infected mice. Valaciclovir therapy, however, allowed persistent infectious virus detection in neural tissues post-treatment.
Area of Science:
- Virology
- Immunology
- Pharmacology
Background:
- Herpes simplex virus type 2 (HSV-2) causes significant morbidity and mortality.
- Antiviral therapies are crucial for managing HSV-2 infections.
Purpose of the Study:
- To evaluate the efficacy of famciclovir and valaciclovir in treating HSV-2 infection in a murine model.
- To investigate the impact of these antivirals on viral clearance from infected tissues.
Main Methods:
- Young adult mice were inoculated with HSV-2 in the ear pinna.
- Mice received oral famciclovir or valaciclovir therapy for varying durations.
- Infectious virus presence was monitored daily in ear pinna, brain stem, and trigeminal ganglia.
Main Results:
- Both famciclovir and valaciclovir significantly reduced clinical signs and mortality.
- Famciclovir treatment resulted in no detectable infectious virus after 9 days.
- Valaciclovir treatment allowed persistent detection of infectious virus in neural tissues for up to 7 days after discontinuation.
Conclusions:
- Famciclovir demonstrated complete viral clearance in this model.
- Valaciclovir's efficacy in neural tissue clearance requires further investigation.
- Potential mechanisms for persistent virus in neural tissue despite valaciclovir therapy are discussed.

